TO THE EDITOR
Chronic diabetic wounds represent one of the most challenging complications of diabetes mellitus, driven by impaired angiogenesis, persistent inflammation, cellular dysfunction, and microvascular injury[1-4]. Recent years have witnessed growing interest in acellular therapies—particularly mesenchymal stem cell (MSC)-derived exosomes-due to their favorable safety profile, low immunogenicity, and potent paracrine effects[4-7]. However, the inherently variable bioactivity of native MSC-derived exosomes remains a major barrier to their clinical translation[8].
Preconditioning strategies such as hypoxia, drug stimulation, and genetic modification have been explored to enhance exosomal potency, but these approaches often introduce biosafety concerns or require complex manufacturing steps[9-11]. In contrast, physical preconditioning methods, especially those using clinically approved devices, offer a unique opportunity to modulate exosome function while preserving translational feasibility[12]. Recent pilot studies further show that a single fractional carbon dioxide (CO2) laser session (30-50 mJ/cm², 5% density) can activate dermal MSCs in situ, increasing their paracrine output of vascular endothelial growth factor (VEGF) and hepatocyte growth factor without adding exogenous agents.
The study by Chen et al[1] recently published in World Journal of Methodology investigates whether low-energy fractional CO2 laser irradiation—already widely used for scar remodeling and dermatologic rejuvenation—can serve as a non-invasive photothermal preconditioning strategy to potentiate the pro-angiogenic function of adipose-derived MSC exosomes. Through integration of thermal profiling, molecular analyses, endothelial functional assays, and in vivo wound healing models, the authors present a comprehensive evaluation of this approach and its underlying mechanisms.
Photothermal conditioning as a modulator of MSC biology and exosomal function
Photothermal conditioning represents an emerging biophysical strategy capable of reshaping the functional landscape of MSCs. Fractional CO2 laser-induced thermal stimulation imposes a controlled stress environment that activates conserved cytoprotective pathways, most notably the heat shock response regulated by HSP90[13]. This adaptive signaling cascade enhances protein homeostasis, stabilizes mitochondrial function, and augments the paracrine output of MSCs, thereby leading to the secretion of exosomes with elevated bioactivity. Such photothermal preconditioning offers a unique advantage over pharmacologic or genetic enhancement methods: It is noninvasive, tunable, and free of exogenous molecular modifiers. Mechanistically, thermal stress alters intracellular redox balance and lipid metabolism, potentially enriching exosomal cargo, particularly bioactive lipids like sphingosine-1-phosphate (S1P), which are known to exert potent angiogenic effects[14]. These findings collectively highlight photothermal modulation as a promising and clinically tractable method to potentiate MSC-derived exosomes for regenerative medicine.
Enhanced angiogenic signaling via S1P/S1PR1-AKT-HIF-1α axis
A central mechanistic insight of laser-activated exosomes lies in their capacity to amplify angiogenic signaling through the S1P/S1PR1-AKT-HIF-1α axis. S1P, a pleiotropic sphingolipid enriched within preconditioned exosomes, engages S1PR1 on endothelial cells, initiating downstream PI3K/AKT phosphorylation[14]. This activation stabilizes HIF-1α, a master regulator of hypoxia-responsive genes, thereby promoting the expression of VEGF-A and other angiogenic mediators[15]. Under diabetic or hyperglycemic conditions-where endothelial dysfunction and impaired AKT signaling are prominent-this pathway becomes particularly relevant. By restoring AKT activity and rescuing HIF-1α suppression, photothermally conditioned exosomes counteract the metabolic and oxidative barriers that ordinarily impair neovascularization. Thus, the S1P/S1PR1-AKT-HIF-1α circuit emerges as a mechanistic bridge linking photothermal stress to enhanced vascular regeneration.
The dual nature of thermal stress: Balancing injury and regeneration
Thermal stress operates as a biological double-edged sword, capable of eliciting either beneficial adaptive responses or detrimental cellular injury depending on intensity, duration, and thermal gradient. Mild to moderate heat exposure, such as that generated by low-energy fractional CO2 lasers, activates heat shock proteins, supports proteostasis, and induces prosurvival pathways that enhance MSC resilience and secretory function[16]. However, excessive thermal loads may trigger mitochondrial dysfunction, reactive oxygen species overproduction, and apoptotic cascades, ultimately diminishing regenerative potential. This delicate equilibrium underscores the importance of precise thermal dosimetry, as the therapeutic window for adaptive stress hardening is narrow and highly contextdependent[17]. The study’s observation that 40 mJ/cm² yields maximal HSP90 expression while avoiding apoptosis illustrates this principle, emphasizing that optimized thermal conditioning can leverage MSC plasticity while minimizing cellular harm.
Exosomal reprogramming: Linking cellular stress to regenerative potency
Exosomes serve as key mediators translating intracellular stress responses into intercellular communication. Under photothermal conditioning, MSCs undergo metabolic and transcriptional reprogramming that reshapes exosomal cargo composition, including proteins, lipids, and regulatory RNAs. The enrichment of S1P within laser-conditioned exosomes provides a compelling example of how stress signaling alters lipid biosynthesis and packaging pathways. More broadly, stress-induced modulation may increase the presence of chaperones, angiogenic factors, and membrane proteins that enhance exosomal uptake and functional delivery[18]. This adaptive reprogramming effectively equips exosomes with a heightened capacity to restore endothelial function, counteract hyperglycemia-induced damage, and promote vascular remodeling. As such, exosomal reprogramming represents a mechanistic conduit through which cellular stress is transformed into enhanced regenerative potency.
In vivo efficacy in diabetic wound healing and its clinical relevance
The in vivo findings offer robust evidence that photothermally enhanced exosomes accelerate diabetic wound healing through sustained angiogenic and reparative effects. Laser-activated exosomes improved wound closure kinetics, increased neovascular density, and promoted collagen deposition, collectively supporting their role in restoring perfusion and tissue architecture in diabetic wounds[19,20]. Importantly, at 14 days, the laser-exosome group exhibited 90% wound closure vs 58% for untreated exosomes (P < 0.001), accompanied by a 2.1-fold higher CD31+ vessel density and significantly more mature, horizontally oriented collagen bundles—early surrogates of reduced scarring. Importantly, these benefits emerged in a pathological environment characterized by chronic inflammation, oxidative stress, and impaired endothelial responsiveness—conditions that typically blunt regenerative interventions[21]. Clinically, such outcomes position photothermal exosome augmentation as a feasible adjunctive therapy for chronic diabetic ulcers, which remain a major cause of morbidity and amputation worldwide. The treatment’s compatibility with existing CO2 laser platforms further enhances translational feasibility, although larger studies are required to standardize dosing regimens, optimize delivery routes, and evaluate long-term functional restoration. Ultimately, the in vivo efficacy demonstrated here lays the groundwork for integrating photothermally conditioned exosomes into future precision wound-healing strategies.
The implications of the present study are multifaceted. First, the demonstration that fractional CO2 laser-induced photothermal conditioning markedly enhances the angiogenic potency of MSC-derived exosomes underscores the therapeutic relevance of biophysical preconditioning as a scalable strategy to augment exosome bioactivity. By elevating exosomal S1P content and activating the S1PR1-AKT-HIF-1α axis, the authors establish a direct mechanistic link between photothermal stress and endothelial functional reprogramming, thereby offering a scientifically coherent framework for improving diabetic wound repair. Second, the in vivo findings-showing accelerated wound closure, increased neovascular density, and improved collagen maturation-reinforce the translational potential of laser-activated exosomes, particularly in the context of chronic ischemic wounds that are refractory to standard care. These data collectively suggest that physiologically tuned photothermal modulation may represent a clinically feasible alternative to chemical or genetic enhancement strategies, which often face concerns regarding biosafety and regulatory complexity.
However, several limitations temper the generalizability of these findings and warrant cautious interpretation. Although photothermal parameters were carefully recorded, the absence of high-resolution thermal dosimetry at the single-cell level limits definitive conclusions regarding the threshold between adaptive heat stress and sublethal injury. Additionally, the exosomal S1P elevation is convincingly demonstrated, but multi-omics profiling (proteomics, lipidomics, and small-RNA sequencing) would be essential to determine whether CO2 laser conditioning induces broader remodeling of exosomal cargo. Finally, the wound model was limited to short-term endpoints, without assessment of long-term functional regeneration (e.g., tensile strength and re-innervation), leaving uncertainties regarding the durability and quality of tissue repair.
To advance these findings toward clinical translation, future research should prioritize several interconnected directions. Mechanistically, integrating proteomic and lipidomic analyses with single-cell transcriptomics would clarify how thermal cues reshape MSC secretion pathways and exosome biogenesis, thereby enabling precision control of exosomal composition. Concurrently, optimization studies using variable laser parameters—including pulse duration, density, and microbeam geometry—could establish standardized conditioning protocols with reproducible biological effects. From a therapeutic perspective, comparative studies evaluating CO2 laser-activated exosomes against chemically or genetically modified exosomes would help delineate relative efficacy, safety profiles, and cost-effectiveness. Moreover, long-term in vivo experiments incorporating biomechanical testing, vascular perfusion imaging, and scar quality assessment are needed to validate functional benefits beyond early wound closure.
Finally, exploring synergistic strategies, such as combining laser-enhanced exosomes with bioengineered hydrogels, oxygen-release scaffolds, or adjunctive metabolic modulators, may further potentiate angiogenesis and improve outcomes in severe diabetic wounds. Early-phase clinical trials will ultimately be required to assess safety, dosing, delivery routes, and inter-individual variability, thereby bridging the gap between current mechanistic insights and real-world wound management. Collectively, these forward-looking efforts will help refine photothermal conditioning into a robust and clinically actionable platform for next-generation regenerative therapies.
